{
  "glycan_biomarkers": [
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "IgG glycosylation",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "Immunoglobulin G",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Immunoglobulin G",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "autoimmune diseases",
        "disease_mapped": "Autoimmune Diseases",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "risk",
        "prognostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "34687018",
        "sentence_in_abstract": "Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "IgG glycosylation",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "Immunoglobulin G",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Immunoglobulin G",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "alloimmune diseases",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "risk",
        "prognostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "34687018",
        "sentence_in_abstract": "Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "IgG glycosylation",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "Immunoglobulin G",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Immunoglobulin G",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "infectious diseases",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "risk",
        "prognostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "34687018",
        "sentence_in_abstract": "Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "IgG glycosylation",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "Immunoglobulin G",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Immunoglobulin G",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "cardiometabolic diseases",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "risk",
        "prognostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "34687018",
        "sentence_in_abstract": "Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases."
      }
    },
    {
      "assessed_biomarker_entity": {
        "glycan_entity": "IgG glycosylation",
        "glycan_entity_change": "altered level",
        "glycoprotein_entity_name": "Immunoglobulin G",
        "glycoprotein_gene_name": "",
        "glycoprotein_mapped": "Immunoglobulin G",
        "glycoenzyme_entity_name": "",
        "glycoenzyme_gene_name": "",
        "glycoenzyme_mapped": ""
      },
      "associated_disease": {
        "disease_name": "malignant diseases",
        "disease_mapped": "",
        "medical_intervention": ""
      },
      "biomarker_role": [
        "risk",
        "prognostic"
      ],
      "sample": {
        "organism": "Humans",
        "specimen_type": "serum",
        "specimen_mapped": ""
      },
      "evidence": {
        "pmid": "34687018",
        "sentence_in_abstract": "Changes in immunoglobulin G (IgG) glycosylation pattern have been observed in a vast array of auto- and alloimmune, infectious, cardiometabolic, malignant, and other diseases."
      }
    }
  ]
}